Literature DB >> 1651644

Diagnosis of acute pyelonephritis in children: comparison of sonography and 99mTc-DMSA scintigraphy.

E Björgvinsson1, M Majd, K D Eggli.   

Abstract

Ninety-one children 1 week to 10 years old with culture-documented febrile urinary tract infection were evaluated with renal sonography and renal cortical scintigraphy by using 99mTc-labeled dimercaptosuccinic acid (DMSA). On the basis of previous experimental studies, DMSA scintigraphy was used as the standard of reference for the diagnosis of acute pyelonephritis. The DMSA scans showed changes consistent with acute pyelonephritis in 63% (57/91) of the patients. Sonograms showed changes consistent with acute pyelonephritis in 24% (22/91) of the whole group and in only 39% (22/57) of the patients with scintigraphically documented acute pyelonephritis. Pertinent sonographic findings were areas of increased cortical echogenicity in 14 patients and decreased echogenicity in eight, including three patients with renal abscesses. Dilatation of the renal collecting system was noted in nine patients and renal enlargement was noted in three. We conclude that renal sonography is a relatively insensitive test for the detection of acute inflammatory changes of renal cortex. Therefore, it should not be used as the primary imaging technique for the diagnosis of acute pyelonephritis. However, sonography is a useful technique in evaluating the nature of the defects seen on the DMSA scan and in detecting obstructive uropathies that may be associated with urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651644     DOI: 10.2214/ajr.157.3.1651644

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

Review 1.  Pediatric applications of abdominal vascular Doppler: Part II.

Authors:  Brian D Coley
Journal:  Pediatr Radiol       Date:  2004-08-05

Review 2.  Urinary tract infections in children.

Authors:  Sherry Sedberry-Ross; Hans G Pohl
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

3.  Intra- and interobserver variability in interpretation of DMSA scans using a set of standardized criteria.

Authors:  K Patel; M Charron; A Hoberman; M L Brown; K D Rogers
Journal:  Pediatr Radiol       Date:  1993

Review 4.  The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections.

Authors:  Brian Becknell; Megan Schober; Lindsey Korbel; John David Spencer
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-25       Impact factor: 5.091

5.  Color Doppler sonography in pyelonephritis.

Authors:  K D Eggli; D Eggli
Journal:  Pediatr Radiol       Date:  1992

6.  Diagnostic significance of 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection.

Authors:  B Jakobsson; S Söderlundh; U Berg
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

7.  Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: Scarring.

Authors:  M V Merrick; A Notghi; N Chalmers; A G Wilkinson; W S Uttley
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

8.  Ultrasound as a screening test for genitourinary anomalies in children with UTI.

Authors:  Caleb P Nelson; Emilie K Johnson; Tanya Logvinenko; Jeanne S Chow
Journal:  Pediatrics       Date:  2014-02-10       Impact factor: 7.124

9.  Sibship size, sibling cognitive sensitivity, and children's receptive vocabulary.

Authors:  Heather Prime; Sharon Pauker; André Plamondon; Michal Perlman; Jennifer Jenkins
Journal:  Pediatrics       Date:  2014-01-27       Impact factor: 7.124

10.  Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor.

Authors:  Kianoush Ansari Gilani; Jamak Modaresi Esfeh; Ali Gholamrezanezhad; Amir Gholami; Setareh Mamishi; Mohammad Eftekhari; Davood Beiki; Armaghan Fard-Esfahani; Babak Fallahi; Arash Anvari
Journal:  Int Urol Nephrol       Date:  2009-10-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.